Pulmonary Surfactant treatment of neonatal mechanical ventilation in the United respiratory hyaline membrane disease care.doc

 PAGE \* MERGEFORMAT 10 Pulmonary Surfactant treatment of neonatal mechanical ventilation in the United respiratory hyaline membrane disease care [Abstract] Objective To evaluate the pulmonary surfactant (lung phospholipid injection, Curosurf) of mechanical ventilation on ventilator joint hyaline membrane disease treatment and care. Methods 25 cases of hyaline membrane disease (HMD ) applications Curosurf, the use of uniform by intratracheal injection of supine position, pressurized oxygen into the air bladder after 2min, and then connected breathing machine, and in the chest taken before and after treatment compared to observation. Results 25 patients after treatment 30min ~ 2h dyspnea were improved, SpO2 increased more than 90%, chest X-ray showed significant improvement in lung field through the brightness. Conclusion grasp the timing and delivery is very important preparation before delivery, delivery confirmation when the position of endotracheal intubation in children using the correct position to the endotracheal tube into Curosurf, uniform distribution of drug in the lungs is to ensure that the key to successful treatment. while children need close observation of vital signs and oxygen saturation changes, strengthening the respiratory tract, strict aseptic is to reduce infection and complications of important measures. [Keywords:] Pulmonary surfactant; respiratory distress syndrome; newborn care Hyaline membrane disease (HMD), also known as neonatal respiratory distress syndrome (NRDS), is shortly after birth appears to respiratory problems and symptoms such as respiratory failure, occurs in premature children, gestational age more The higher incidence of small, its causes and the lack of pulmonary surfactant (PS) on [1]. Curosurf is a natural extract in lung PS, can reduce the surface tension of the lung to improve the stability of end-expiratory alveolar to promote the reopening of collapsed alveoli, increasing functional residual volume, imp